期刊文献+

Mayo评分与Child分级评估肝硬化患者预后 被引量:5

Comparison of Mayo Score with Child Score on Clinical Assessment in Patients with Liver Cirrhosis
下载PDF
导出
摘要 目的:通过研究Mayo评分和Child分级与肝硬化患者预后的关系,比较两种方法预测肝硬化患者预后的价值。方法:回顾分析106例肝炎后肝硬化患者的临床资料,计算入院当天Mayo评分与Child分值,通过ROC曲线及截断值进行比较分析。结果:各组患者生存者与死亡者的Mayo评分与Child分值均有显著差异(P<0.05),3个月与2年生存期的患者两体系ROC曲线下面积有显著差异(P<0.05),而生存期1年的患者两体系ROC曲线下面积无显著差异(P>0.05)。结论:Mayo评分与Child分级均准确评估各生存期预后;Mayo评分适宜评估急、危重患者,而Child分级较适宜评估中长期患者。Mayo评分不仅适用于预测原发性胆汁性肝硬化患者预后,同样适用于肝炎后肝硬化患者。 Objective: To compare Mayo score and Child score on the evaluation of prognosis in patients with liver cirrhosis, after studying the relationship between Mayo score. Child score and the prognosis of those patients. Methods: The clinical data of 106 patients with liver cirrhosis caused by hepatitis were retrospectively studied, Mayo score and Child score on admission day were calculated and compared with reeeiver operating characteristic (ROC) curves. Results: Mayo score and Child score showed significantly difference (P〈0.05) between patients who survived and those who died. The ared under the ROC curves were significantly different (P〈0.05) between patients surviving for three months and those surviving for two years, while the ared under the ROC curves didn't have any obvious difference (P〉0. 05) among patients who survived for one year. Conclusion: Mayo score and Child score can accurately assess the prognosis of patients in different survival periods. Mayo score is used to patients in acute and critical periods, while Child score for patients of long-medium term. Mayo score can also assess the prognosis in patients with primary biliary cirrhosis and those with liver cirrhosis caused by hepatitis.
作者 秦向荣 张维
出处 《中国临床医学》 北大核心 2007年第5期644-646,共3页 Chinese Journal of Clinical Medicine
关键词 肝硬化 Mayo评分 Child-Pugh体系 受试者特征曲线 Live cirrhosis Mayo score Child Pugh system Receiver operating characteristic (ROC) curve
  • 相关文献

参考文献6

  • 1Klion FM, Fabry TL, Palmer M, et al. Prediction of survival of patients with primary biliary cirrhosis. Examination of the Mayo Clinic model on a group of patients with known endpoint[J]. Gastroenterology, 1992,102:310-313.
  • 2Dickson ER. Gramhsch PM, Fleming TR, et al. Prognosis in pri mary biliary cirrhosis: model for decision making[J]. Hepatology, 1989,10:1-7.
  • 3Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease; an evolution from child to MELD. Mayo End-stage Liver Disease[J]. Hepatology. 2001,33:473-475.
  • 4李琴,王宝恩,贾继东.肝功能分级的演变及特点:从Child到MELD[J].中华肝脏病杂志,2004,12(5):319-320. 被引量:78
  • 5Oellerich M, Burdelski M, Lautz HU. et al. Predictors of one year pretransplant survival in patients with cirrhosis[J]. Hepatology, 1991,14:1029-1034.
  • 6Rcisman Y, van Dam GM, Gips CH, et al. Survival prohabilities of Pugh Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic mod el. Euricterus Project Management Group[J]. Hepatogastroenterology,1997,44 : 982-989.

二级参考文献10

  • 1Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
  • 2Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child- Turcotte criteria in medically treated cirrhosis. Hepatology,1984, 4: 430-435.
  • 3Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987, 7: 660-664.
  • 4Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 5Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Hepatology, 1996, 23: 164-176.
  • 6Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage or international normalized ratio?Hepatology, 1996, 24: 1392-1394.
  • 7Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology, 2001, 33:473-475.
  • 8McCaughan GW, Strasser SI. To MELD or not to MELD?Hepatology, 2001, 34: 215-216.
  • 9Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003,52: 134-139.
  • 10Child Ⅲ CG, Turcotte JG. Surgery and Portal Hypertension. In:Child Ⅲ CG, ed. The liver and portal hypertension. Philadelphia:Saunders, 1964. 50.

共引文献77

同被引文献48

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部